Accelevir Diagnostics is a biotechnology company developing innovative assays for ultra-rare analytes in infectious diseases and beyond.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 18, 2017 | Grant | $1.19M | 1 | National Science Foundation | — | Detail |
Jun 24, 2016 | Grant | $224.55K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |